Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PKM6 | ISIN: US79957L1008 | Ticker-Symbol:
NASDAQ
24.01.25
21:34 Uhr
37,400 US-Dollar
-0,720
-1,89 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SANARA MEDTECH INC Chart 1 Jahr
5-Tage-Chart
SANARA MEDTECH INC 5-Tage-Chart

Aktuelle News zur SANARA MEDTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrBiomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.217SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and...
► Artikel lesen
DiSanara MedTech expects Q4 revenue in the range of $25.7M to $26.2M5
DiSanara MedTech reshapes executive team with new CFO and CAO2
DiSanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024261Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara...
► Artikel lesen
SANARA MEDTECH Aktie jetzt für 0€ handeln
DiSanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd284OsStic® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually(1); arrangement leverages Sanara's existing call points and commercial...
► Artikel lesen
DiSanara MedTech Inc. Expands Executive Leadership Team with New Appointments1
DiSanara MedTech Inc. - 8-K, Current Report-
04.12.24Sanara MedTech Inc. - 8-K, Current Report-
12.11.24Sanara MedTech Inc. Reports Third Quarter 2024 Results121FORT WORTH, TX, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology...
► Artikel lesen
12.11.24Sanara MedTech Inc. - 8-K, Current Report-
07.10.24Sanara MedTech Inc. Announces Changes to Its Board of Directors1
23.09.24Sanara MedTech Inc. signs CEO Nixon to new employment terms1
23.09.24Sanara MedTech Inc. - 8-K, Current Report2
11.09.24Sanara MedTech Inc. - 8-K, Current Report1
11.09.24Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC1
12.08.24Sanara MedTech Inc. - 8-K, Current Report1
12.08.24Sanara MedTech GAAP EPS of -$0.41 misses by $0.20, revenue of $20.2M beats by $1.1M1
12.08.24Sanara MedTech Inc. Announces Second Quarter 2024 Results193FORT WORTH, TX, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ: SMTI), a medical technology...
► Artikel lesen
13.05.24Sanara MedTech Inc. Announces First Quarter 2024 Results248FORT WORTH, TX, May 13, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ: SMTI), a medical technology...
► Artikel lesen
05.04.24Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer223FORT WORTH, TX, April 05, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ: SMTI), a medical technology...
► Artikel lesen
Seite:  Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1